Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer

BACKGROUND/AIMS: To determine the efficacy and toxicity of docetaxel as a third-line therapy for patients with relapsed gastric cancer who have undergone modified oxaliplatin-fluorouracil (m-FOLFOX)-4 and modified irinotecan-fluorouracil (m-FOLFIRI) regimens. METHODS: We analyzed 33 patients who had...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Lee, Ji Hyun, Kim, Sung-Hyun, Oh, Sung Yong, Lee, Suee, Lee, Hojin, Lee, Hye Jung, Kim, Hyo-Jin
Format: Artigo
Jezik:Inglês
Izdano: The Korean Association of Internal Medicine 2013
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3654129/
https://ncbi.nlm.nih.gov/pubmed/23682225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2013.28.3.314
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items